scholarly article | Q13442814 |
P356 | DOI | 10.1021/JM030504I |
P8608 | Fatcat ID | release_qgwh6ka6r5afnfd4am47zkpup4 |
P698 | PubMed publication ID | 15055996 |
P2093 | author name string | Paul D Lyne | |
Sonya Zabludoff | |||
Susan Ashwell | |||
Chun Deng | |||
David A Cosgrove | |||
Peter W Kenny | |||
John J Wendoloski | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1962-1968 | |
P577 | publication date | 2004-04-01 | |
P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
P1476 | title | Identification of compounds with nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual screening | |
P478 | volume | 47 |
Q44823868 | Automated molecule editing in molecular design |
Q56916101 | Chapter 9 Molecular Similarity: Advances in Methods, Applications and Validations in Virtual Screening and QSAR |
Q27998704 | Combining docking with pharmacophore filtering for improved virtual screening |
Q36477542 | Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach |
Q31139520 | Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening |
Q56979637 | Designing a ligand for pharmaceutical purposes |
Q27659340 | Discovery of Novel Fibroblast Growth Factor Receptor 1 Kinase Inhibitors by Structure-Based Virtual Screening |
Q54346146 | Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors. |
Q36477457 | Finding protein kinase hits using structural information |
Q36117828 | First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents. |
Q33616659 | Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening |
Q24656051 | Identification of xenoestrogens in food additives by an integrated in silico and in vitro approach |
Q49959079 | Impact of novel N-aryl piperamide NO donors on NF-κB translocation in neuroinflammation: rational drug-designing synthesis and biological evaluation. |
Q54577952 | Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation. |
Q36654909 | New approaches to molecular cancer therapeutics |
Q36939959 | Novel inhibitors of checkpoint kinase 1. |
Q36549367 | PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness |
Q40007226 | Pharmacophore modelling and synthesis of quinoline-3-carbohydrazide as antioxidants |
Q38028528 | Pharmacophore-based virtual screening: a review of recent applications |
Q36266998 | Reengineering the pharmaceutical industry by crash-testing molecules |
Q27649874 | Rescoring Docking Hit Lists for Model Cavity Sites: Predictions and Experimental Testing |
Q35229529 | Reviewing ligand-based rational drug design: the search for an ATP synthase inhibitor |
Q33270545 | Scoring functions and enrichment: a case study on Hsp90. |
Q33238328 | Structure-based development of target-specific compound libraries |
Q33271049 | Ultrafast de novo docking combining pharmacophores and combinatorics |
Q51714832 | Using protein-ligand docking to assess the chemical tractability of inhibiting a protein target. |
Q34626368 | Virtual screening of chemical libraries for drug discovery |
Q39998714 | Virtual screening to identify lead inhibitors for bacterial NAD synthetase (NADs). |
Search more.